Native American Research Centers for Health (NARCH) (S06 Clinical Trial Optional)
- Not stated
- Not stated
- Not stated
Official announcement on nih_guide · opens the funder's page. Always confirm dates there.
Summary
The purpose of the Native American Research Centers for Health (NARCH) program is to fund federally-recognized American Indian/Alaska Native (AI/AN) Tribes and Tribal colleges or universities, Tribal health programs, or Tribal organizations (collectively, federally-recognized Tribes and Tribal Entities) to support health-related… […]
Other topics in this solicitation
Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2024, 2025, and 2026 (P50 Clinical Trial Required)
National Institute of General Medical Sciences Predoctoral Basic Biomedical Sciences Research Training Program (T32)
Limited Competition: National Primate Research Centers (P51) (Clinical Trials Not Allowed)
NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Required)
NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Not Allowed)
Vet-LIRN Capacity-Building Project and Equipment Grants (U18)
$2.5M
The rest of this announcement — free with an account
- The full announcement text, not the first two sentences
- All 10 review criteria reviewers score this against, extracted from this announcement
- Whether you are eligible — career stage, institution type, and the windows that close before the deadline does
- What similar funded projects received, from 219,000 past awards
More from National Institutes of Health
NIH Director’s Early Independence Award (DP5 Clinical Trial Optional)
$350k
Integrating Biospecimen Science Approaches into Clinical Assay Development (U01 Clinical Trial Not Allowed)
Computational Approaches to Curation at Scale for Biomedical Research Assets (R01 Clinical Trial Not Allowed)
$250k
HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)
$350k